Top Markets
#1 GoPlus Security GoPlus Security +31.58%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.85%
#3 Tutorial Tutorial +18.60%
#4 Status Status +15.77%
#5 Pons Pons +14.32%
#6 Wrapped NXM Wrapped NXM +14.12%
#7 Verus Coin Verus Coin +12.97%
#8 o1.exchange o1.exchange +10.06%
#9 SkyAI SkyAI +9.28%
#10 DMT-NAT DMT-NAT +8.92%
Coin of the day
GoPlus Security GoPlus Security
Settings
Language
ENGLISH
Currency
USD
Theme
PreveCeutical Medical Inc. PreveCeutical Medical Inc.

PreveCeutical Medical Inc.

PREV
Rank in Stocks #33931
PreveCeutical Medical Inc. is a health sciences firm dedicated to creating... PreveCeutical Medical Inc. is a health sciences firm dedicated to creating preventative and therapeutic solutions, employing compounds that are either organic or identical to natural substances. Its robust product pipeline features the Cannabinoid Sol-Gel Delivery system, a cannabinoid-based technology designed for nose-to-brain delivery, aiming to alleviate symptoms associated with pain, inflammation, epileptic seizures, and diverse neurological conditions. Also in development is the BSV Peptide Program, which focuses on hindering cancer's advancement, alongside a non-addictive analgesic for effective pain relief. The company is also progressing with a Dual Gene Therapy project to address type 2 diabetes and obesity. Complementing these initiatives, PreveCeutical is involved in the creation of various products derived from medicinal cannabis. The company is headquartered in Vancouver, Canada.
Share Price
$0.01100905
Last synced: 2026-08-13
Market Cap
$6.59M
Change (1 day)
0.00%
Change (1 year)
-49.29%
Country
CA
Trade PreveCeutical Medical Inc. (PREV)

Category

Healthcare
P/S ratio for PreveCeutical Medical Inc. (PREV)
P/S ratio as of 2026 TTM: 0
According to PreveCeutical Medical Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for PreveCeutical Medical Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE